Back to top
more

Centene (CNC)

(Delayed Data from NYSE)

$25.91 USD

25.91
17,547,780

-0.16 (-0.61%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $25.90 -0.01 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (245 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.

Tracey Ryniec headshot

Screening for Basic Value Stocks

by Tracey Ryniec

Tracey Ryniec, Zacks Value Stock Strategist, finds 3 value stocks with Strong Buy and Buy recommendations.

Kinjel Shah headshot

5 Low Price-to-Book Value Stocks to Buy in May

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and SAN are some such stocks.

Derek Lewis headshot

3 Stocks to Buy Following Robust Results

by Derek Lewis

Several companies have posted stellar quarterly results throughout the Q1 cycle, with their momentum likely to follow through in the near term on the back of raised outlooks.

Zacks Equity Research

Should Value Investors Buy Centene (CNC) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Here's Why Centene (CNC) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

by Zacks Equity Research

StoneCo, Centene, CVS Health and Pfizer have been highlighted in this Screen of The Week article.

Mark Vickery headshot

Markets Mostly Higher: Dow Kept Down by UNH Selling

by Mark Vickery

While UnitedHealthcare fights another unforeseen headwind, NVIDIA helped the Nasdaq cruise higher.

Sumit Singh headshot

4 Value Picks to Ride the Market Rebound After US-China Trade Thaw

by Sumit Singh

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. STNE, CNC, CVS & PFE boast a low P/CF ratio.

Zacks Equity Research

Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Adaptive Biotechnologies (ADPT) and Centene (CNC) have performed compared to their sector so far this year.

Zacks Equity Research

ENSG Gains 3% on Q1 Earnings Beat, Higher Patient Days Aid

by Zacks Equity Research

Ensign Group's first-quarter results gain on improved skilled services revenues and higher rental revenues. Management projects 2025 adjusted EPS to be within $6.22-$6.38.

John Blank headshot

A Fed Meeting Clarifies the Outlook: Global Week Ahead

by John Blank

The Fed's policy meeting follows data showing a contraction in first-quarter U.S. GDP and pressure from the president on the central bank to cut interest rates.

Zacks Equity Research

Cigna Q1 Earnings Beat Estimates on Evernorth Health Strength

by Zacks Equity Research

CI increases adjusted earnings guidance for 2025 to $29.60 per share from the previous estimate of $29.50.

Zacks Equity Research

What Makes Centene (CNC) a New Strong Buy Stock

by Zacks Equity Research

Centene (CNC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Best Value Stocks to Buy for May 1st

by Zacks Equity Research

CNC and FSFG made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 1, 2025.

Zacks Equity Research

New Strong Buy Stocks for May 1st

by Zacks Equity Research

FIX, RITM, CCEP, CRS and CNC have been added to the Zacks Rank #1 (Strong Buy) List on May 1, 2025.

Zacks Equity Research

Zacks.com featured highlights Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander

by Zacks Equity Research

Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander have been highlighted in this Screen of The Week article.

Zacks Equity Research

Humana's Q1 Earnings Beat Estimates on CenterWell Segment Strength

by Zacks Equity Research

HUM's first-quarter results reflect higher primary care revenues and a well-performing Medicare stand-alone PDP business, partly offset by elevated operating costs.

Zacks Equity Research

Tenet Beats Q1 Earnings on Strong Ambulatory Unit, Ups '25 EPS View

by Zacks Equity Research

THC's first-quarter results benefit on the back of higher net revenue per case and the expansion of service lines within the Ambulatory Care unit. It currently expects 2025 adjusted EPS within $11.99-$13.12.

Zacks Equity Research

CNC vs. HUM: Which Stock Is the Better Value Option?

by Zacks Equity Research

CNC vs. HUM: Which Stock Is the Better Value Option?

Kinjel Shah headshot

Boost Your Portfolio With These 5 Low Price-to-Book Stocks

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, MD, PFE, STNE and SAN are some such stocks.

Derek Lewis headshot

Earnings Season: 3 Companies Raising Guidance

by Derek Lewis

Raising guidance? In this uncertainty? These three companies say yes.

Zacks Equity Research

Encompass Health Beats Q1 Earnings Estimates, Ups '25 EPS View

by Zacks Equity Research

EHC's Q1 results benefit on the back of discharge growth and expansion endeavors, partly offset by high operating costs. It currently expects 2025 adjusted EPS from continuing operations within $4.85-$5.10.

Zacks Equity Research

Should Value Investors Buy Centene (CNC) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Centene Q1 Earnings Beat Estimates on Marketplace Business Strength

by Zacks Equity Research

CNC's Q1 results benefit from improved premiums as a result of a strong PDP business, partly offset by elevated operating costs. It currently expects 2025 premium and service revenues within $164-$166 billion.

Zacks Equity Research

Centene (CNC) Reports Q1 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.